돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 43392생성일: 2026년 10월 23일

Water → 4-{5-[(4-{[4-(Trifluoromethyl)phenyl]sulfonyl}-1-piperazinyl)carbonyl]-2-pyridinyl}morpholine

https://huagongshe.com/ko/reaction/43392

반응식

참여 물질

역할이름HCID투입량
반응물WaterHCID 962—
반응물1-HydroxybenzotriazoleHCID 75771—
반응물DiisopropylethylamineHCID 81531—
반응물1-[4-(Trifluoromethyl)benzenesulfonyl]piperazineHCID 2554578—
반응물Methanaminium, N-((1H-benzotriazol-1-yloxy)(dimethylamino)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 2733084—
반응물6-Morpholinonicotinic AcidHCID 2776460—
용매DimethylformamideHCID 6228—
생성물4-{5-[(4-{[4-(Trifluoromethyl)phenyl]sulfonyl}-1-piperazinyl)carbonyl]-2-pyridinyl}morpholineHCID 2611210278.2%

반응 단계

To a solution of 1-{[4-(trifluoromethyl)phenyl]sulfonyl}piperazine (Description 1) (80 mg, 0.272 mmol) in DMF (5 ml) were added 6-(4-morpholinyl)-3-pyridinecarboxylic acid (56.6 mg, 0.272 mmol), HOBT.H2O (41.6 mg, 0.272 mmol), HBTU (103 mg, 0.272 mmol) and DIPEA (0.142 ml, 0.816 mmol) and the reaction mixture was stirred at room temperature for 2 h. The DMF was evaporated in vacuo then 5 ml of DCM were added and washed with saturated aqueous NaHCO3 solution (5 ml), dried on a phase separation cartridge and evaporated in vacuo. The crude material was dissolved in MeCN/DMSO 1:1 and purified by MDAP. The desired fractions were collected and concentrated under vacuo giving the title compound (103 mg).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08536183B2
출처 데이터셋uspto-grants-2013_09
ORD IDord-c38249caf2674a54ad692beb27cfd819
출처 메모uspto-grants-2013_09